Insight Molecular Diagnostics Inc. (IMDX) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts IMDX Hot Sheet
Join SI Premium – FREE
Insight Molecular Diagnostics Inc. (NASDAQ: IMDX) reported Q2 EPS of ($0.23), $0.01 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $240 thousand versus the consensus estimate of $470.85 thousand.
For earnings history and earnings-related data on Insight Molecular Diagnostics Inc. (IMDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rapid7, Inc. (RPD) Tops Q2 EPS by 9c; offers guidance
- Alpha Tau Medical Ltd. (DRTS) Misses Q2 EPS by 12c
- EagleRock Land, LLC (EROK) Reports Q2 Loss of $0.29
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
